Leukocyte redistribution: Effects of beta blockers in patients with chronic heart failure

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  von Haehling, Stephan ^a,b   Schefold, Joerg C ^a   Jankowska, Ewa ^a,c   Doehner, Wolfram ^a   Springer, Jochen ^a   Strohschein, Kristin ^b   Genth Zotz, Sabine ^d   Volk, Hans Dieter ^a   Poole Wilson, Philip ^b   Anker, Stefan D ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MILITARY HOSPITAL   (Poland)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CARVEDILOL; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1; INTERLEUKIN 6; METOPROLOL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; URIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HELPER CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PHARMACOLOGICAL BLOCKING; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CYTOLOGY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; AGED; CASE-CONTROL STUDIES; FLOW CYTOMETRY; HEART FAILURE; HUMANS; LEUKOCYTES; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 68149092195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006411     Document Type: Article

References (22)

1. Anker SD (1998) Catecholamine levels and treatment in chronic heart failure. Eur Heart J 19(Suppl F): F56-F61.
2. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638.
3. Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90: 464-470.
4. von Haehling S, Anker SD (2005) Future prospects of anticytokine therapy in chronic heart failure. Expert Opin Investig Drugs 14: 163-176.
5. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al. (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 19;102: 3060-3067.
6. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, et al. (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103: 2055-2059.
7. Abraham WT, Hensen J, Schrier RW (1990) Elevated plasma noradrenaline concentrations in patients with low-output cardiac failure: dependence on increased noradrenaline secretion rates. Clin Sci (Lond) 79: 429-435.
8. Kinugawa T, Ogino K, Osaki S, Kato M, Igawa O, et al. (2002) Prognostic significance of exercise plasma noradrenaline levels for cardiac death in patients with mild heart failure. Circ J 66: 261-266.
9. von Haehling S, Genth-Zotz S, Bolger AP, Kalra PR, Kemp M, et al. (2005) Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. Am J Cardiol 95: 885-889.
10. Doehner W, Rauchhaus M, Godsland IF, Egerer K, Niebauer J, et al. (2002) Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol 83: 73-81.
11. Maisel AS, Fowler P, Rearden A, Motulsky HJ, Michel MC (1989) A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin Pharmacol Ther 46: 429-439.
12. Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M (1996) Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10: 77-91.
13. Eriksson B, Hedfors E (1977) The effect of adrenaline, insulin and hydrocortisone on human peripheral blood lymphocytes studied by cell surface markers. Scand J Haematol 18: 121-128.
14. Yu DT, Clements PJ (1976) Human lymphocyte subpopulations effect of epinephrine. Clin Exp Immunol 25: 472-479.
15. Maisel AS, Michel MC (1990) Beta-adrenoceptor control of immune function in congestive heart failure. Br J Clin Pharmacol 30(Suppl1): 49S-53S.
16. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM (1974) Modulation of inflammation and immunity by cyclic AMP. Science 184: 19-28.
17. Berkenbosch F, de Goeij DE, Rey AD, Besedovsky HO (1989) Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 50: 570-576.
18. von Haehling S, Schefold JC, Springer J, Anker SD (2008) The cholesterol paradox revisited: heart failure, systemic inflammation, and beyond. Heart Fail Clin 4: 141-151.
19. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91: 988-998.
20. Dibbs Z, Thornby J, White BG, Mann DL (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33: 1935-1942.
21. Meldrum DR, Donnahoo KK (1999) Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a postbypass cardiorenal syndrome. J Surg Res 85: 185-199.
22. Maisel AS, Knowlton KU, Fowler P, Rearden A, Ziegler MG, Motulsky HJ, Insel PA, Michel MC (1990) Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest 85: 462-467.